English Funding Success For Roche’s Rozlytrek In NSCLC

Entrectinib Fills ‘Significant’ Unmet Need In Advanced Disease

 
• By Ian Schofield
  
Benefit_Cost
UK HTA body NICE weighs up the benefits and costs of new treatments • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe